Nanoparticles made out of gold to cure eye diseases
A new study by a professor of the faculty of medicine at Université Laval suggests that the use of nanoparticles made out of gold could improve the effectiveness of eye disease treatments.
Professor Élodie Boisselier holds a patent for a technology that allows an ophthalmic drug to adhere to the mucous membrane of the eye thanks to the use of gold nanoparticles. This type of technology can improve the life of patients with cataracts, and with its post-surgical treatment.
Learn more about this new technology: https://bit.ly/3oHC1Gt
Posted on: Feb 3, 2021
¡Paraguay@! Te recordamos que la primera convocatoria CALDO-BECAL para doctorados en Canadá sigue abierta hasta el próximo 28 ...
Posted on: Feb 2, 2021
¡Estudiantes, investigadores y profesionales uruguayos! Les queremos invitar a participar de nuestro próximo webinar. ...
Posted on: Jan 27, 2021
Two discoveries from researchers and scientists of Université Laval are being featured in the list of the 10 discoveries of ...
Posted on: Jan 22, 2021
An international team of researchers, including Canadian researchers from McMaster University and the University of Calgary, ...
Posted on: Jan 20, 2021
Did you know a team of scientists from the University of Toronto is working to develop a treatment for vision loss by using ...
Posted on: Jan 15, 2021
¡Excelentes noticias! ¿Eres un estudiante Colombian@? ¿Quieres estudiar tu maestría o doctorado en universidades líderes en ...
Posted on: Jan 11, 2021
From healthcare professionals and environmentalists to policymakers and researchers—we can all find a personal & ...
Posted on: Jan 6, 2021
Excelentes noticas para estudiantes Uruguay@s! La Agencia Nacional de Investigación e Innovación (ANII) abrió el pasado 29 de ...
Posted on: Dec 21, 2020
Did you know that a Western University graduate astronomy student spotted a previously undiscovered asteroid flashing through ...
Request a Contact
To request a contact from CALDO for support and additional information, please provide the information below.